SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Article Details

Citation

Rodriguez MS, Dargemont C, Hay RT

SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

J Biol Chem. 2001 Apr 20;276(16):12654-9. Epub 2000 Dec 21.

PubMed ID
11124955 [ View in PubMed
]
Abstract

SUMO-1 is a small ubiquitin-related modifier that is covalently linked to many cellular protein targets. Proteins modified by SUMO-1 and the SUMO-1-activating and -conjugating enzymes are located predominantly in the nucleus. Here we define a transferable sequence containing the PsiKXE motif, where Psi represents a large hydrophobic amino acid, that confers the ability to be SUMO-1-modified on proteins to which it is linked. Whereas addition of short sequences from p53 and IkappaBalpha, containing the PsiKXE motif, to a carrier protein is sufficient for modification in vitro, modification in vivo requires the additional presence of a nuclear localization signal. Thus, protein substrates must be targeted to the nucleus to undergo SUMO-1 conjugation.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Cellular tumor antigen p53P04637Details
NF-kappa-B inhibitor alphaP25963Details